-
Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D, Maringer K, Bernal-Rubio D, Shabman RS, Simon V, Rodriguez-Madoz JR, Mulder LC, Barber GN, Fernandez-Sesma A, 2012: DENV inhibits type Ⅰ IFN production in infected cells by cleaving human STING[J]. PLoS Pathog, 8, e1002934-. doi: 10.1371/journal.ppat.1002934
-
Akkina R, Berges BK, Palmer BE, Remling L, Neff CP, Kuruvilla J, Connick E, Folkvord J, Gagliardi K, Kassu A, Akkina SR, 2011: Humanized Rag1-/- gammac-/- mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes[J]. PLoS ONE, 6, e20169-. doi: 10.1371/journal.pone.0020169
-
Ashour J, Morrison J, Laurent-Rolle M, Belicha-Villanueva A, Plumlee CR, Bernal-Rubio D, Williams KL, Harris E, Fernandez-Sesma A, Schindler C, Garcia-Sastre A, 2010: Mouse STAT2 restricts early dengue virus replication[J]. Cell Host Microbe, 8, 410-421. doi: 10.1016/j.chom.2010.10.007
-
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI, 2013: The global distribution and burden of dengue[J]. Nature, 496, 504-507. doi: 10.1038/nature12060
-
Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA, 2007: Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage[J]. J Virol, 81, 5518-5526. doi: 10.1128/JVI.02575-06
-
Crouse J, Kalinke U, Oxenius A, 2015: Regulation of antiviral T cell responses by type Ⅰ interferons[J]. Nat Rev Immunol, 15, 231-242. doi: 10.1038/nri3806
-
Green AM, Beatty PR, Hadjilaou A, Harris E, 2014: Innate immunity to dengue virus infection and subversion of antiviral responses[J]. J Mol Biol, 426, 1148-1160. doi: 10.1016/j.jmb.2013.11.023
-
Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW, 2010: Dengue: a continuing global threat[J]. Nat Rev Microbiol, 8, S7-16. doi: 10.1038/nrmicro2460
-
Hotta S, 1952: Experimental studies on dengue. I. Isolation, identification and modification of the virus[J]. J Infect Dis, 90, 1-9. doi: 10.1093/infdis/90.1.1
-
Jin X, Lee M, Shu J, 2015: Dengue fever in China: an emerging problem demands attention[J]. Emerg Microbes Infect, 4, e3-. doi: 10.1038/emi.2015.3
-
Kato F, Tajima S, Nakayama E, Kawai Y, Taniguchi S, Shibasaki K, Taira M, Maeki T, Lim CK, Takasaki T, Saijo M, 2017: Characterization of large and small-plaque variants in the Zika virus clinical isolate ZIKV/Hu/S36/Chiba/2016[J]. Sci Rep, 7, 16160-. doi: 10.1038/s41598-017-16475-2
-
Li G, Pan P, He Q, Kong X, Wu K, Zhang W, Liu Y, Huang H, Liu J, Zhang Z, Wu Lai X, Liu X, Wu J, 2017: Molecular epidemiology demonstrates that imported and local strains circulated during the 2014 dengue outbreak in Guangzhou, China[J]. Virol Sin, 32, 63-72. doi: 10.1007/s12250-016-3872-8
-
Liang H, Yang R, Liu Z, Li M, Liu H, Jin X, 2018: Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice[J]. PLoS ONE, 13, e0194860-. doi: 10.1371/journal.pone.0194860
-
Moser LA, Boylan BT, Moreira FR, Myers LJ, Svenson EL, Fedorova NB, Pickett BE, Bernard KA, 2018: Growth and adaptation of Zika virus in mammalian and mosquito cells[J]. PLoS Negl Trop Dis, 12, e0006880-. doi: 10.1371/journal.pntd.0006880
-
Orozco S, Schmid MA, Parameswaran P, Lachica R, Henn MR, Beatty R, Harris E, 2012: Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor[J]. J Gen Virol, 93, 2152-2157. doi: 10.1099/vir.0.045088-0
-
Perry ST, Buck MD, Lada SM, Schindler C, Shresta S, 2011: STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type Ⅰ interferon receptor[J]. PLoS Pathog, 7, e1001297-. doi: 10.1371/journal.ppat.1001297
-
Plummer EM, Shresta S, 2014: Mouse models for dengue vaccines and antivirals[J]. J Immunol Methods, 410, 34-38. doi: 10.1016/j.jim.2014.01.001
-
Prestwood TR, Morar MM, Zellweger RM, Miller R, May MM, Yauch LE, Lada SM, Shresta S, 2012: Gamma interferon (IFN-gamma) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-alpha/beta receptor-deficient mice[J]. J Virol, 86, 12561-12570. doi: 10.1128/JVI.06743-11
-
Sabin AB, Schlesinger RW, 1945: Production of immunity to dengue with virus modified by propagation in mice[J]. Science, 101, 640-642. doi: 10.1126/science.101.2634.640
-
Sarathy VV, Milligan GN, Bourne N, Barrett AD, 2015: Mouse models of dengue virus infection for vaccine testing[J]. Vaccine, 33, 7051-7060. doi: 10.1016/j.vaccine.2015.09.112
-
Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E, 2006: Murine model for dengue virus-induced lethal disease with increased vascular permeability[J]. J Virol, 80, 10208-10217. doi: 10.1128/JVI.00062-06
-
St John AL, Rathore APS, 2019: Adaptive immune responses to primary and secondary dengue virus infections[J]. Nat Rev Immunol, 19, 218-230. doi: 10.1038/s41577-019-0123-x
-
Stabell AC, Meyerson NR, Gullberg RC, Gilchrist AR, Webb KJ, Old WM, Perera R, Sawyer SL, 2018: Dengue viruses cleave STING in humans but not in nonhuman primates, their presumed natural reservoir[J]. Elife, 7, e31919-. doi: 10.7554/eLife.31919
-
Sun J, Li M, Wang Y, Hao P, Jin X, 2017: Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence[J]. Vaccine, 35, 6308-6320. doi: 10.1016/j.vaccine.2017.09.063
-
Tan GK, Ng JK, Lim AH, Yeo KP, Angeli V, Alonso S, 2011: Subcutaneous infection with non-mouse adapted Dengue virus D2Y98P strain induces systemic vascular leakage in AG129 mice[J]. Ann Acad Med Singapore, 40, 523-532. doi: 10.2298/VSP1112079P
-
WHO (2009) In: Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control, New edn. WHO Guidelines Approved by the Guidelines Review Committee, Geneva
-
Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, Liao CL, Lin YL, 2012: Dengue virus targets the adaptor protein MITA to subvert host innate immunity[J]. PLoS Pathog, 8, e1002780-. doi: 10.1371/journal.ppat.1002780
-
Zhao H, Zhang FC, Zhu Q, Wang J, Hong WX, Zhao LZ, Deng YQ, Qiu S, Zhang Y, Cai WP, Cao WC, Qin CF, 2016: Epidemiological and Virological Characterizations of the 2014 Dengue Outbreak in Guangzhou. China[J]. PLoS ONE, 11, e0156548-. doi: 10.1371/journal.pone.0156548